Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
by Dominic Tyer
Sanofi US has branched out in its blogging efforts and this week launched Speaking of Sanofi, its first corporate blog.
Managed by the company's corporate reputation and digital communications director Stacy Burch, the blog will include perspectives from Sanofi companies like its vaccine arm Sanofi Pasteur, biotech business Genzyme and animal health company Merial.
Alhough it's still early days for the blog, Sanofi already has an impressive list of contributors planned for Speaking of Sanofi.
These include the head of its North America R&D Hub Marc Bonnefoi, SVP of commercial operations at Sanofi Pasteur Damian Braga and CEO of Genzyme David Meeker.
Outlining Sanofi's plans in an introductory post Burch said Sanofi would also be inviting industry leaders to contribute guest posts.
The new blog adds to the Discuss Diabetes blog Sanofi launched in January 2011 and is further evidence of a resurgence of industry interest in the medium.
The time required to run a blog, certainly when compared with 'lighter' options -at least in terms of writing - like Twitter, has tended to keep their numbers down.
But this year has seen a higher than average number of pharma companies begin blogs, from AstraZeneca's Lab Talk and Lilly's expansion of its LillyPad blog, to Bayer UK's Diabetes Care blog and Boehringer Ingelheim's plans for The Future Just Happened.